JPS527981A - Pharmaceutical composition containing benzazepine derivatives - Google Patents

Pharmaceutical composition containing benzazepine derivatives

Info

Publication number
JPS527981A
JPS527981A JP51079404A JP7940476A JPS527981A JP S527981 A JPS527981 A JP S527981A JP 51079404 A JP51079404 A JP 51079404A JP 7940476 A JP7940476 A JP 7940476A JP S527981 A JPS527981 A JP S527981A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition containing
benzazepine derivatives
containing benzazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51079404A
Other languages
English (en)
Japanese (ja)
Inventor
Kaizaa Kaaru
Gurabu Bendoruton Robaato
Erizabesu Setoraa Pouretsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/592,708 external-priority patent/US4011319A/en
Priority claimed from US05/602,042 external-priority patent/US4052506A/en
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of JPS527981A publication Critical patent/JPS527981A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP51079404A 1975-07-02 1976-07-01 Pharmaceutical composition containing benzazepine derivatives Pending JPS527981A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/592,708 US4011319A (en) 1975-07-02 1975-07-02 Pharmaceutical compositions and methods involving benzazepine derivatives
US05/602,042 US4052506A (en) 1975-08-05 1975-08-05 Pharmaceutical compositions and method of producing anti-parkinsonism activity

Publications (1)

Publication Number Publication Date
JPS527981A true JPS527981A (en) 1977-01-21

Family

ID=27081519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51079404A Pending JPS527981A (en) 1975-07-02 1976-07-01 Pharmaceutical composition containing benzazepine derivatives

Country Status (10)

Country Link
JP (1) JPS527981A (nl)
AU (1) AU507272B2 (nl)
CA (1) CA1079639A (nl)
DE (1) DE2629887A1 (nl)
FR (1) FR2315934A1 (nl)
GB (1) GB1561305A (nl)
IE (1) IE43920B1 (nl)
IL (1) IL49931A (nl)
LU (1) LU75269A1 (nl)
NL (1) NL7607184A (nl)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
JPS54135787A (en) * 1978-04-12 1979-10-22 Smithkline Corp Substituted benzazepin
JPS5615207A (en) * 1979-07-10 1981-02-14 Smithkline Corp Antihypertensive composition having synergism
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA777444B (en) * 1977-01-19 1978-10-25 Smithkline Corp Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines having dopaminergic activity
US4104379A (en) * 1977-01-19 1978-08-01 Smithkline Corporation Substituted 1-alkylthiophenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4490392A (en) * 1977-08-11 1984-12-25 Tanabe Seiyaku Co., Ltd. Benzylalcohol derivative and process for preparing
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
JPS54135787A (en) * 1978-04-12 1979-10-22 Smithkline Corp Substituted benzazepin
JPS6365663B2 (nl) * 1978-04-12 1988-12-16 Smithkline Beckman Corp
JPS5615207A (en) * 1979-07-10 1981-02-14 Smithkline Corp Antihypertensive composition having synergism
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体

Also Published As

Publication number Publication date
LU75269A1 (nl) 1977-02-18
NL7607184A (nl) 1977-01-04
CA1079639A (en) 1980-06-17
AU507272B2 (en) 1980-02-07
IL49931A0 (en) 1976-08-31
FR2315934B1 (nl) 1978-11-17
GB1561305A (en) 1980-02-20
IL49931A (en) 1981-12-31
IE43920L (en) 1977-01-02
DE2629887A1 (de) 1977-01-20
AU1554076A (en) 1978-01-05
FR2315934A1 (fr) 1977-01-28
IE43920B1 (en) 1981-07-01

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
GB1518444A (en) N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
JPS57163314A (en) Medicinal composition containing benzazepine derivative
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
JPS527981A (en) Pharmaceutical composition containing benzazepine derivatives
KE3219A (en) Pharmaceutical compositions
IL49280A (en) Pharmaceutical compositions containing substituted o-hydroxy-benzophenone derivatives
ZA766663B (en) Novel heterocyclic compounds and pharmaceutical composition containing them
GB1552460A (en) Diphenylacetamide derivatives processes for their preparation and pharmaceutical compositions containing them
GB1555991A (en) Pharmaceutical compositions containing adenosine derivatives
IL53146A0 (en) Pharmaceutical compositions containing certain pyrrolidone derivatives
IL48791A0 (en) Novel penicillin derivatives,their preparation and pharmaceutical compositions containing them
AU1541376A (en) Pharmaceutical composition
ZA761012B (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
IL50058A0 (en) Polycyclic compounds,their preparation and pharmaceutical compositions containing them
IL49161A0 (en) New diazepine derivatives,their manufacture and pharmaceutical compositions containing them
IE43955L (en) Pharmaceutical composition
GB1547198A (en) Pharmaceutical compositions containing phenoxypropylamine derivatives
ZA763806B (en) Pharmaceutical compositions